1110059G10Rik Activators
Activators of the protein KIAA1143 homolog are compounds that enhance the functional activity of this protein through a variety of cellular mechanisms. Forskolin and its derivative 8-Br-cAMP elevate intracellular cyclic AMP (cAMP) levels, which indirectly promote the activation of protein kinase A (PKA). PKA has the capacity to phosphorylate substrates, including the protein KIAA1143 homolog, thus potentially enhancing its activity. Similarly, IBMX works to prevent the degradation of cAMP, bolstering cAMP-dependent pathways that may lead to the activation of the KIAA1143 homolog. Direct activation of protein kinase C (PKC) by PMA could result in the phosphorylation and activation of the KIAA1143 homolog if it is a target for this kinase. Additionally, ionomycin can increase intracellular calcium levels, possibly stimulating calcium-dependent signaling cascades that may phosphorylate and activate the KIAA1143 homolog.
Furthermore, the S1P receptor agonist, Sphingosine-1-phosphate, initiates a signaling cascade that can enhance the activity of the KIAA1143 homolog through G-protein-coupled receptor pathways. LY294002, while not mentioned in detail here, could also play a role in modulating pathways that influence the activity of the KIAA1143 homolog. These various activators, by affecting different molecular switches within the cell, can converge to upregulate the activity of the KIAA1143 homolog, demonstrating the complexity of intracellular signaling and its capacity to control protein function. Further, the Sphingosine-1-phosphate (S1P) signaling pathway, which can be stimulated by S1P itself, is capable of modulating the activity of kinases and phosphatases that, in turn, could enhance the activity of protein KIAA1143 homolog.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
A cAMP analog that activates PKA, potentially enhancing the phosphorylation status and therefore the activity of Uncharacterized protein KIAA1143 homolog. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP degradation, thus potentially enhancing cAMP/PKA-mediated pathways that could lead to the activation of Uncharacterized protein KIAA1143 homolog. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Direct activator of protein kinase C (PKC), which could phosphorylate and thus enhance the activity of Uncharacterized protein KIAA1143 homolog if it is a substrate of PKC. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which could activate calcium-dependent kinases that phosphorylate and enhance the activity of Uncharacterized protein KIAA1143 homolog. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P receptor agonist that could activate the SIP receptor, potentially leading to downstream signaling events that enhance the activity of Uncharacterized protein KIAA1143 homolog via kinases in the SIP signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that could lead to alterations in downstream AKT signaling, indirectly enhancing the activity of Uncharacterized protein KIAA1143 homolog if it is part of the PI3K/AKT pathway. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
p38 MAPK inhibitor that could enhance Uncharacterized protein KIAA1143 homolog activity by inhibiting competing pathways or by stress response modulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits multiple kinases and could enhance Uncharacterized protein KIAA1143 homolog activity indirectly by affecting signaling networks in which Uncharacterized protein KIAA1143 homolog might be involved. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor leading to increased cytosolic calcium, which could activate calcium-dependent pathways and thereby enhance the activity of Uncharacterized protein KIAA1143 homolog. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor that could lead to the activation of Uncharacterized protein KIAA1143 homolog by selectively inhibiting kinases that oppose its activity. | ||||||